Cypherpunk Technologies Inc. filings document the company’s transition from Leap Therapeutics, its Zcash-focused digital asset treasury strategy, and its continuing biopharma subsidiary activities. Form 8-K reports cover financial results, material agreements, warrant modifications connected to private placement financing, equity incentive plan approvals, and exchange-listing compliance notices.
Proxy materials describe annual meeting matters, board composition, stockholder voting procedures, executive compensation governance, and equity plan authorization. The filing record also reflects capital-structure disclosures involving common stock, warrants, and incentive plan shares, along with governance changes related to director retirements and committee service.
Cypherpunk Technologies Inc. (CYPH) is the subject of an amended Schedule 13D reporting the position of Winklevoss-affiliated entities after a major crypto-mining asset acquisition and related warrant exercises.
On August 17, 2026, Winklevoss Treasury Investments, LLC (WTI) exercised pre-funded warrants for 16,570,852 shares of common stock at $0.001 per share, paid in cash from WTI working capital. The same day, Cypherpunk Mining LLC, a wholly owned subsidiary of Cypherpunk Technologies, entered an Asset Purchase Agreement with Moria Mining, LLC and WTI to acquire specified mining equipment, hosting agreements and related assets for an aggregate purchase price of $33,333,333, payable in an APA pre-funded warrant to purchase 43,290,042 shares at $0.001 per share. WTI now directly holds 24,854,613 shares (beneficially 19.9% of the common stock) based on 124,335,234 shares outstanding after the warrant exercise, and holds additional pre-funded, APA pre-funded and common warrants subject to a 19.99% Beneficial Ownership Limitation. Cypherpunk plans to seek stockholder approval to permit issuance of APA warrant shares above 5,377,442 and to remove other exercise limitations.
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported insider-related entity activity involving pre-funded warrants and common stock held through Winklevoss-associated entities. Winklevoss Treasury Investments, LLC (WTI), a subsidiary of Winklevoss Capital Fund, LLC, received Pre-Funded Warrants to purchase 43,290,042 shares of common stock under an Asset Purchase Agreement dated August 17, 2026, as consideration for the sale of certain assets and rights. On the same date, WTI exercised pre-funded warrants covering 16,570,852 underlying common shares at an exercise price of $0.001 per share, resulting in indirect ownership of 24,854,613 common shares held by WTI. The pre-funded warrants are exercisable immediately, have no expiration date, and are subject to a 19.99% beneficial ownership cap based on the issuer’s outstanding common stock. Each reporting person disclaims beneficial ownership except to the extent of its or his pecuniary interest.
Cypherpunk Technologies Inc. entered into an Asset Purchase Agreement under which its subsidiary acquired mining equipment and hosting agreements from Moria Mining for an aggregate purchase price of $33,333,333. The consideration is a pre-funded warrant issued to Winklevoss Treasury Investments to purchase 43,290,042 shares of common stock at an exercise price of $0.001 per share, with anti-dilution adjustments and no expiration until fully exercised. The warrant is subject to a 19.99% beneficial-ownership cap and, pending stockholder approval, limits initial issuance above 5,377,442 shares, approximately 4.99% of shares outstanding before signing. Cypherpunk will seek stockholder approval at its next annual meeting to permit full warrant exercise and remove other exercise limits.
The acquired fleet provides about 4.2 GSol/s of Equihash hashrate, representing roughly 18% of the Zcash network, making Cypherpunk Mining the largest Zcash mining fleet. A related amendment to the Registration Rights Agreement expands “Registrable Securities” to include current and future Cypherpunk securities held by Winklevoss Treasury Investments. The company highlights that its ZEC treasury of 323,394.38 ZEC, about 1.92% of circulating supply, combined with mining economics and an addressable market cited at over $250 million per year, is central to its privacy-focused strategy.
Cypherpunk Technologies Inc. reports a sharp earnings swing as its new digital-asset-focused strategy takes hold. For the quarter ended June 30, 2026, the company recorded net income of $39.4 million, versus a $16.6 million loss a year earlier, driven mainly by a $46.0 million unrealized gain on the fair value of its Zcash-linked embedded derivative. Operating expenses fell to $4.7 million from $16.9 million as cancer R&D spending was largely wound down, while general and administrative costs rose with higher stock-based compensation and digital-asset-related support.
On the balance sheet, Cypherpunk held $7.6 million in cash and equivalents and $129.4 million of digital assets receivable tied to 323,394.38 ZEC tokens, bringing total assets to $143.0 million and stockholders’ equity to $139.3 million as of June 30, 2026. Operating activities used $6.1 million of cash in the first half, while the company invested $18.5 million (including a $5.0 million SAFE in Zcash Open Development Lab) and raised $19.2 million via an at-the-market share program. Management believes existing cash plus remaining ATM capacity are sufficient to fund operations for at least 12 months, but results remain highly sensitive to ZEC price volatility.
Cypherpunk Technologies reported strong headline results for the quarter ended June 30, 2026. Net income was $39.4 million, or $0.18 per diluted share, compared with a net loss of $16.6 million a year earlier. The swing was mainly driven by a $46.0 million unrealized gain on the fair value of the company’s Zcash (ZEC) digital asset treasury, as ZEC’s price rose from $243.35 to $400.09 during the quarter.
Operating expenses shifted materially. Research and development fell to $0.2 million from $10.5 million, reflecting completed clinical trials and prior headcount reductions, while general and administrative expenses increased to $4.5 million from $1.8 million due largely to higher stock‑based compensation and payroll. Cash and cash equivalents were $7.6 million at June 30, 2026, and digital assets receivable were $129.4 million, contributing to total assets of $143.0 million and stockholders’ equity of $139.3 million.
The company highlighted its biotechnology subsidiary, Leap Therapeutics. Leap reached alignment with the FDA on the design of a proposed Phase 3 trial of sirexatamab (DKN‑01) in DKK1‑high second‑line metastatic colorectal cancer and announced peer‑reviewed publication of Phase 2 DeFianCe study results, which support DKK1‑high patients as a biomarker‑defined population for a future registrational trial.
Cypherpunk Technologies Inc. reports that Nasdaq has notified it of a deficiency in meeting the $1.00 per share minimum closing bid price required for continued listing on the Nasdaq Capital Market, after the stock traded below this threshold for 30 consecutive business days.
The notice is a deficiency notice, not an immediate delisting, and the company’s shares continue to trade on Nasdaq. Cypherpunk has 180 days, until January 19, 2027, to regain compliance by maintaining a closing bid of at least $1.00 for a minimum of 10 consecutive business days. The company may qualify for an additional 180-day period if it meets other listing standards and notifies Nasdaq of its intent to cure, potentially including a reverse stock split.
The company states it will closely monitor its share price and consider plans to regain compliance, while cautioning there is no assurance it will succeed within the available compliance periods.
Cypherpunk Technologies Inc. director Richard Christian M received a grant of 75,000 restricted stock units (RSUs). Each RSU will convert on a 1-for-1 basis into shares of the company’s common stock, par value $0.001 per share, under the 2025 Equity Incentive Plan for no cash consideration.
The RSUs will vest on June 15, 2027. Subject to award terms and applicable tax withholdings, the company will settle the vested RSUs in common stock no later than the fifteenth day of the third calendar month following the calendar year in which the grant date occurs.
Cypherpunk Technologies Inc. director Oei Khing Djien received a grant of 100,000 restricted stock units (RSUs). The award carries a conversion ratio of 1 RSU for 1 share of Cypherpunk Technologies common stock, par value $0.001 per share, and was issued for no cash consideration under the company’s 2025 Equity Incentive Plan.
The RSUs will vest on June 15, 2027. Subject to the RSU terms and applicable tax withholdings, Cypherpunk Technologies will settle the vested RSUs in common stock no later than the fifteenth day of the third calendar month following the calendar year in which the grant date occurs. Following this grant, the filing shows 100,000 derivative units held directly.
Cypherpunk Technologies Inc. reported that director Thomas John Dietz received a grant of 100,000 restricted stock units. Each RSU will convert into one share of common stock under the company’s 2025 Equity Incentive Plan and was issued for no cash consideration.
The RSUs vest on June 15, 2027. After vesting, and subject to applicable tax withholdings and award terms, the company will settle the RSUs in common stock by a specified deadline, increasing the director’s potential equity stake if he remains eligible through the vesting date.
Cypherpunk Technologies Inc. reported that director Patricia A. Martin received a grant of 75,000 restricted stock units (RSUs). These RSUs were issued for no cash consideration under the company’s 2025 Equity Incentive Plan and will convert into common shares on a 1-for-1 basis.
The RSUs vest on June 15, 2027. Subject to tax withholding and award terms, the company will settle the vested RSUs in common stock no later than the fifteenth day of the third calendar month following the calendar year of the grant date. Following this award, Martin holds 75,000 RSUs directly.